← back to search

Ke Cao

Sunnybrook Health Science Centre · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Mitochondrial Function and Pathology, MicroRNA in disease regulation, Adipose Tissue and Metabolism, and Advanced biosensing and bioanalysis techniques.
h-index
23
citations
3,011
works
55
NIH funding
primary concept
Medicine
email

Recent publications

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet 2023cited by 982position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.